In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548-Reference-Cited by-同舟云学术

In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548

Published:2013-08-09 Issue:19 Volume:19 Page:5434-5443
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kähkönen Esa,Jambor Ivan,Kemppainen Jukka,Lehtiö Kaisa,Grönroos Tove J.,Kuisma Anna,Luoto Pauliina,Sipilä Henri J.,Tolvanen Tuula,Alanen Kalle,Silén Jonna,Kallajoki Markku,Roivainen Anne,Schäfer Niklaus,Schibli Roger,Dragic Martina,Johayem Anass,Valencia Ray,Borkowski Sandra,Minn Heikki

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bimodal MRI/Fluorescence Nanoparticle Imaging Contrast Agent Targeting Prostate Cancer;Nanomaterials;2024-07-10

2. Synthesis and Evaluation of the First 68Ga-Labeled C-Terminal Hydroxamate-Derived Gastrin-Releasing Peptide Receptor-Targeted Tracers for Cancer Imaging with Positron Emission Tomography;Molecules;2024-06-28

3. Evaluation of gastrin-releasing peptide receptor, prostate-specific membrane antigen, and neurotensin receptor 1 as potential biomarkers for accurate prostate cancer stratified diagnosis;EJNMMI Research;2024-06-16

4. Synthesis and Evaluation of Novel 68Ga-Labeled [D-Phe6,Leu13ψThz14]bombesin(6-14) Analogs for Cancer Imaging with Positron Emission Tomography;Pharmaceuticals;2024-05-11

5. Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy;Journal of Peptide Science;2024-05-06